Cita APA (7a ed.)

Canadian Agency for Drugs and Technologies in Health. (2018). CADTH Canadian Drug Expert Committee recommendation (final) Letermovir (Prevymis -- Merck Canada Inc.) indication: Cytomegalovirus infection, prophylaxis. CADTH.

Cita Chicago Style (17a ed.)

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Recommendation (final) Letermovir (Prevymis -- Merck Canada Inc.) Indication: Cytomegalovirus Infection, Prophylaxis. Ottawa (ON): CADTH, 2018.

Cita MLA (9a ed.)

Canadian Agency for Drugs and Technologies in Health. CADTH Canadian Drug Expert Committee Recommendation (final) Letermovir (Prevymis -- Merck Canada Inc.) Indication: Cytomegalovirus Infection, Prophylaxis. CADTH, 2018.